Dr. Nadauld presents recently published abstract at the American Association for Cancer Research conference
New studies by Intermountain Precision Genomics reveal that precision medicine improves survival in advanced cancer patients without increasing costs.
A new study by Intermountain Medical Center researchers found that using advanced clinical decision support tools reduces mortality for the 1.1 million patients in the Unites States who are treated for pneumonia each year.
Researchers have developed new smartphone technology to help screen patients for a number of adrenal gland diseases, including Cushing’s syndrome.
Researchers presented results of the study at the 2014 American Diabetes Association Scientific Sessions